Tianhong Dai is an assistant professor with the Harvard Medical School. He is considered a world leader in antimicrobial blue light therapy for infections, and a world expert in animal models of wound infections using bioluminescent microbes. He is the author and co-author of more than 80 peer-reviewed publications. Dr. Dai’s research has been supported by the NIH (R01 and R21), DoD and other funding sources.
Michael R Hamblin Ph.D. was a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School for 25 years, and is now a Distinguished Visiting Professor at the University of Johannesburg, South Africa. His research interests include photodynamic therapy, photobiomodulation, drug delivery, nanomedicine, and tissue engineering. He has published over 720 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 10 patents. He is Editor-in Chief of "Photobiomodulation, Photomedicine and Laser Surgery", Associate Editor for 10 journals, on the editorial board of a further 60 journals. He has an h-factor 142 with 80,000 citations. He has authored/edited 36 textbooks on PDT, photomedicine, and nanomedicine including 13 SPIE proceedings. Dr. Hamblin was elected as a Fellow of SPIE in 2011, received the 1st Endre Mester Lifetime Achievement Award from NAALT in 2017, the Outstanding Career Award from the Dose Response Society, the 1st Ali Javan award for Photobiomodulation Basic Science Research from WALT in 2018, and the Lifetime Achievement Award from European Medical Laser Association in 2022.
Athanassios Tsakris is currently Professor and Head of the Department of Microbiology at the Medical School, University of Athens, Greece. He graduated as an MD from the Medical School of University of Athens, Greece, and completed his training in Medical Microbiology at North Middlesex Hospital and the Central Public Health Laboratory, London. He received his PhD from the London School of Hygiene and Tropical Medicine. He is a Fellow in Medical Microbiology at the Royal College of Pathologists, London. His research interests include the development of diagnostic methods for detecting antimicrobial resistance mechanisms and infection control activities. Prof. Tsakris is an evaluator of grant applications in several international organizations and serves as editor or on the editorial boards in microbiology/infectious diseases scientific journals.
Prof. Soroush Sardari is a full professor of Pasteur Institute of Iran. He did Ph.D. from Faculty of Pharmacy and Pharmaceutical Sciences, the University of Alberta in addition to obtaining Pharm.D from TUMS. He worked as an assistant professor at the University of Cape Breton, Sydney. From his work, he has registered 4 USPTO patents and 9 national patents, published more than 100 papers, 6 books and more than 100 abstracts in national and international congresses. He has worked as the co-editor of three scientific journals from 2006 to present and as the reviewer of more than 9 journals during 1993-present. Since 1992, he has supervised more than 50 Ph.D. and M.Sc. dissertations.
Antonio Di Biagio is currently holding the position of physician in the infectious diseases clinic of IRCCS San Martino-IST, Genoa – Italy. He teaches infectious diseases and public health in School of Medicine at University of Genoa He is involved in the clinical and therapeutical management of HIV-infected patients care at the inpatient and outpatient clinic of the hospital. As part of his academic work, she has developed clinical research programmes in Europe, on the issues of HIV-chronic hepatitis B and C, as well as co-morbidities associated with the use of antiretrovirals. He is involved in the development of HIV Guidelines with Italian Society of Infectious Diseases. He is the main authors of over 180 peer-reviewed publications on these subjects. He is member of PENTA, CISAI, ICONA scientific committee.
Dr. Diamond is Chair and Professor of the Department of Experimental Therapeutics at City of Hope in Duarte, CA. With over 30 years of experience in vaccine research, his expertise is sought after by many federal agencies. Dr. Diamond has authored over 120 peer-reviewed publications, 20 patents, and conducts both Phase 1 and Phase 2 clinical trials using CMV and cancer vaccines. His current portfolio includes Salmonella delivery of cancer vaccines to develop an oncologic therapeutic to control the progression of pancreatic ductal adenocarcinoma. Dr. Diamond is responsible for a multi-disciplinary department comprised of 34 faculty, physicians, postdoctoral fellows, technicians, and graduate students.
Dr. El Solh is a Professor of Medicine and Anesthesiology at the State University of New York at Buffalo. He is the Director of Research at the VA Western New York Healthcare System. He holds a MPH in Health Administration from the Medical College of Wisconsin. He has published more than 250 publications between peer reviewed original papers, abstracts, and book chapters. He holds three patents on screening and diagnosis of sleep disorders.
Sobhan Ghafourian is an Assistant Professor of Medical Microbiology at the Department of Medical Microbiology, Faculty of Medicine, Ilam University OF Medical Sciences, Ilam, Iran. His previous experience was head of Health Technology Development Center, Ilam University of Medical sciences. He is recognised by his peers as an expertise in his field with his appointments as internal and external examiner at both undergraduate and postgraduate levels and had been invited as speakers at seminars and conferences. He is actively involved in research as evident by securing several research grants, having many postgraduate students and extensive publications. His research interests are in bacteriology (particularly Persister cells, Toxin antitoxin systems and antibiotic resistant bacteria).
Dr. Aditya Gupta is a practicing dermatologist and medical director of Mediprobe Research in London, Ontario. In addition, Dr. Gupta is a professor in the Department of Medicine at the University of Toronto (Ontario, Canada), lecturing on topics such as mycology, fungal infections and antifungal treatments. He is also a visiting professor in the Department of Dermatology at Tel Aviv University and an adjunct professor in the Department of Dermatology at the University of Rome “G. Marconi”. Dr. Gupta has published over 600 articles with 15 original studies in mycology in the last 3 years.
Dr. Saeed Khan is currently a senior regulatory research scientist and head of the shelf life extension program of pharmaceutical drug products at FDA. He is also Adjunct Professor of Oncology and Radiology and Adjunct Director of Drug Discovery Center at Johns Hopkins Oncology at Johns Hopkins Medicine. He received his MS and Ph.D. degree in Biomedical Sciences from M.D Anderson Cancer Houston. Dr. Khan has been involved in 60 plus publications in peer-reviewed scientific journals and 10 international patents on cancer drugs. He is a recipient of numerous awards such as Outstanding Investigator Award from the National Cancer Institute.
Graduated from Mendeleev University, Moscow. PhD and DSc Theses awarded by MU-Sofia. Editor: METAL-BASED DRUGS; ASIAN CHEM LETT; INT J DRUG DISCOV; INT J CURR CHEM; REC PAT ANTI–CANCER DRUG DISCOV; J PHARMA & PHARM SCI. Member of Editorial Boards: ANTI-CANCER AGENTS MED CHEM; WORLD J VIROL; IND J PURE & APPL PHYS; THE OPEN CANCER JOURNAL; REC PAT ANTI-INF DRUG DISCOV; INFECT & DRUG RES; BRIT J MED MED RES; INT J CHEM; INT J ENVIR SCI; DATASET PAPERS CHEM; PEERTECHZ J MED CHEM RES. Published over 130 papers (citations>3000; IF>140; h-index: 27).
Dr. Vikas Kumar, Assistant Professor (Pharmacognosy) at the, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Allahabad, India has been working on traditional medicine in drug discovery leading to the development of therapeutic leads from natural resources. His research work is highlighted on screening, evaluation, formulation and standardization of herbal drugs with their validation to ensure quality, efficacy and safety. He has made innovative, outstanding and original contributions both in research and education in the area of natural products.
Prof. Lee is a director in the National Leading Research Laboratory and a professor in the Department of Biological Sciences at Myongji University. He has more than 25 years of experience of inr reseaech fiels such as antimicrobials, multidrug resistance, and biochemistry and X-ray crystal structure of ESBLs (extended-spectrum β-lactamases) and carbapenemases as well as structure-based drug design, and stem cells (regenerative medicine). He has authored more than 100 scientific papers published in peer-reviewed journals, many of which were the first in the field of Infectious Diseases and Drug Resistance.
Dr. Manzin received his Medical Degree in 1983. He is Specialist in Hygiene and Preventive Medicine, and in Microbiology. Since 2006 he is a Full Professor of Microbiology and Virology at the Medical School at the University of Cagliari, Italy. He is currently leading a lab active in clinical microbiology and virology, study of pathogen-host interplay, use of molecular tools in diagnosis of infectious diseases, and study of the human virome and microbiome. He is the Director of Specialization School of Microbiology and Virology at the University of Cagliari. He authored nearly 100 scientific manuscripts on various aspects of basic and clinical microbiology and infectious diseases.
Carole Ayoub Moubareck is a Pharmacist who specialized in microbiology (PhD from the Paris Descartes University) then pursued a post-doctoral work at the Institut Pasteur of France. She was responsible of the National Reference Center of Antibiotic Resistance in France for several years and since 2014 she is an Associate Professor at Zayed University in Dubai. Her research interests are in controlling infectious diseases by monitoring the emergence and spread of resistant bacteria to antibiotics, characterizing the related resistance mechanisms and investigating potential new therapeutic options.
Dr. Suprabhat Mukherjee is currently working as an Assistant Professor at Department of Animal Science & Coordinator of Biochemistry, Kazi Nazrul University, India. He did his Ph.D. from Visva-Bharati University, India and having research experience at INSERM, Paris, France and NEHU, India. He has co-authored more than 40 research publications and 5 book chapters till date. For his research, he has got several awards. Dr. Mukherjee’s research interest is immunobiology of inflammatory and infectious diseases as well as development of effective drugs.
Dr. Utpal Nandi is currently working as Scientist in the PK-PD, Toxicology and Formulation Division of Indian Institute of Integrative Medicine (CSIR), Jammu, India. His current research work is focused on preclinical pharmacokinetics of drug/drug-like molecules & phytotherapeutics for drug induced toxicities. He has published more than forty research papers in various reputed journals.
Prof. S.I. Ofoefule is a Professor of Pharmacy. He has nearly 23years of experience as a Pharmacy Educator and Researcher, 13 years as a Professor. Previously Prof. Ofoefule served as Dean of Faculty at university of Nigeria and university of Uyo respectively. He is currently a Head of Department and Coordinator, Drug Delivery and Nanotechnology Research Unit at The University of Nigeria, Nsukka.He has authored more than 100 research publications, two Pharmacy books and one technical report. Prof. Ofoefule is also an adjunct faculty member at University of Uyo and University Port Harcourt, Nigeria.
Dr. Rodriguez obtained a doctorate (Ph.D.) in Chemistry from the Universidad de Buenos Aires (1990). Then, he was a Postdoctoral Fellow at the National Institutes of Health (1992-1993) He was appointed Assistant Professor (1997), and then Professor (2005) both at the Department of Organic Chemistry, Universidad de Buenos Aires. He has published more than 70 scientific publications and is a named inventor of 5 U.S. patents. His fields of interest are the design of antiparasitic and antiviral agents as well as total synthesis of compounds of pharmacological importance.
Dr. Nagendran Tharmalingam is a Microbiologist/ Medical laboratory scientist. He finished his Bachelors and Masters at Department of Microbiology, Bharathidasan University, India. After working as a Microbiologist for a while, he went to South Korea to pursue his Doctoral studies at Yonsei University. Later, he moved to the U.S.A and worked as a Research Associate at Rhode Island Hospital. He is actively involved in various anti-infectives research projects and teaching research to Grad students. His research interests include novel anti-infective molecules, repurposing clinical molecules as anti-infectives and its evaluation in vitro and in vivo against Helicobacter pylori and ESKAPE pathogens.
Dr. Syed Sarim Imam earned his Ph.D. from the Faculty of Pharmacy, Jamia Hamdard, New Delhi, India. Dr. Imam has more than 10 years of total experience in teaching and research, and is presently working as Associate Professor at Glocal School of Pharmacy, Glocal University, Saharanpur, India. His research interests include drug delivery, brain targeting, formulation optimization, and lipid based delivery systems. Dr. Imam has contributed 12 book chapters in different publishers, such as Elsevier, CRC and Springer. Furthermore, he has a list of more than 50 research/review manuscripts in journals of international repute.
Dr Da-Yong LU, born in July, 1962 in Shanghai. oc/professor; ed/ph D Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 2005, MS, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 1986, BS, Shanghai Medical University (Now Fudan University affiliated) in1982; He is working as an associated professor at Shanghai University, Shanghai200444, PR China. Undergo the studies of cancer pathology, biochemistry, pharmacology and clinical therapeutics, especially on the pharmacological studies of new Chinese anticancer agent probimane and MST-16 and antimetastatic targets of fibrinogen and sialic acids and individualized cancer chemotherapy (ICC) since 1982. His interest is focused on the basic studies of cancer biology, pathology, treatment, origins of life, human suicide study, human viral infectious diseases, human metabolic diseases and other field of science disciplines. He is serving as an editorial member of several reputed international journals. He was the first author of more than 100 original scientific articles in international journals and three books published by UK, US and Germany-based publication companies.
Dr Faissal TARRASS, Md, PhD, is a private practice nephrologist, serving patients at the Center of Hemodialysis 2 Mars in Casablanca, Morocco. Dr. TARRASS is internationally recognized in the Marquis Who's Who of the World. He currently serves on the Editorial Board of many peer-reviewed medical Journals, and his is an author of numerous articles, paper presentations and book chapters. His research interests are focused on environmental nephrology and sustainable issues in healthcare. Dr. Tarrass had received numerous awards and recognition for his work. He had received in 2019 the award of the outstanding clinician by the venus international medical foundation. For more information on Dr TARRASS biography please visit www.dialyse2mars.com, www.dialysecasablanca.com or http://bios.marquiswhoswho.com/faissal_tarrass/nephrologist/8327125